Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
SGRY logo SGRY
Upturn stock ratingUpturn stock rating
SGRY logo

Surgery Partners Inc (SGRY)

Upturn stock ratingUpturn stock rating
$21.95
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/27/2025: SGRY (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

12 Analysts rated it

Well-followed company, solid analyst reports, reliable data for confident investing.

1 Year Target Price $31.36

1 Year Target Price $31.36

Analysts Price Target For last 52 week
$31.36Target price
Low$18.87
Current$21.95
high$33.97

Analysis of Past Performance

Type Stock
Historic Profit -42.14%
Avg. Invested days 23
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/27/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 2.81B USD
Price to earnings Ratio -
1Y Target Price 31.36
Price to earnings Ratio -
1Y Target Price 31.36
Volume (30-day avg) 12
Beta 1.94
52 Weeks Range 18.87 - 33.97
Updated Date 06/30/2025
52 Weeks Range 18.87 - 33.97
Updated Date 06/30/2025
Dividends yield (FY) -
Basic EPS (TTM) -1.53

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -6.09%
Operating Margin (TTM) 11.55%

Management Effectiveness

Return on Assets (TTM) 3.97%
Return on Equity (TTM) -0.35%

Valuation

Trailing PE -
Forward PE 35.46
Enterprise Value 6445832045
Price to Sales(TTM) 0.89
Enterprise Value 6445832045
Price to Sales(TTM) 0.89
Enterprise Value to Revenue 2.03
Enterprise Value to EBITDA 13.16
Shares Outstanding 128160000
Shares Floating 25441921
Shares Outstanding 128160000
Shares Floating 25441921
Percent Insiders 1.51
Percent Institutions 110.89

Analyst Ratings

Rating 4
Target Price 31.36
Buy 1
Strong Buy 8
Buy 1
Strong Buy 8
Hold 3
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Surgery Partners Inc

stock logo

Company Overview

overview logo History and Background

Surgery Partners Inc. was founded in 2004. It has grown through acquisitions and organic growth to become a leading operator of surgical facilities and related services in the United States.

business area logo Core Business Areas

  • Surgical Facility Operations: Owns and operates a network of ambulatory surgery centers (ASCs) and surgical hospitals.
  • Ancillary Services: Provides physician services, optical services, and other ancillary services.

leadership logo Leadership and Structure

Wayne DeVeydt is the Chief Executive Officer. The company has a typical corporate structure with a board of directors and various executive leadership positions overseeing different business functions.

Top Products and Market Share

overview logo Key Offerings

  • Ambulatory Surgery Centers (ASCs): Operates over 180 ASCs. These centers provide outpatient surgical procedures. Market share data is variable, but Surgery Partners holds a significant portion of the fragmented ASC market. Competitors include AmSurg (now part of Envision Healthcare), United Surgical Partners International (USPI), and HCA Healthcare (HCA).
  • Surgical Hospitals: Operates surgical hospitals. Competitors include HCA Healthcare (HCA), Tenet Healthcare (THC), and Community Health Systems (CYH).

Market Dynamics

industry overview logo Industry Overview

The healthcare services industry, particularly the market for ambulatory surgery centers, is experiencing growth driven by an aging population, advancements in surgical techniques that allow for more outpatient procedures, and a focus on cost containment.

Positioning

Surgery Partners is positioned as a leading independent operator of surgical facilities, offering a lower-cost alternative to traditional hospital settings.

Total Addressable Market (TAM)

The US ambulatory surgery center market is estimated to be worth over $40 billion annually. Surgery Partners is positioned to capture a significant portion of this TAM through acquisitions and organic growth.

Upturn SWOT Analysis

Strengths

  • Extensive network of surgical facilities
  • Focus on high-growth surgical specialties
  • Strong relationships with physicians
  • Experienced management team
  • Diversified revenue streams

Weaknesses

  • High debt levels
  • Exposure to reimbursement rate changes
  • Dependence on physician referrals
  • Integration risks from acquisitions
  • Highly competitive market

Opportunities

  • Further acquisitions of surgical facilities
  • Expansion into new geographic markets
  • Growth in demand for outpatient surgical procedures
  • Development of new service lines
  • Partnerships with health systems and payers

Threats

  • Changes in healthcare regulations and reimbursement policies
  • Increased competition from other surgical facility operators
  • Rising operating costs
  • Economic downturn
  • Physician shortages

Competitors and Market Share

competitor logo Key Competitors

  • HCA
  • THC
  • USPI (United Surgical Partners International)

Competitive Landscape

Surgery Partners competes with larger hospital systems and other ASC operators. Its advantages include a focus on outpatient surgery and a cost-effective operating model. Disadvantages include its smaller size and higher debt levels compared to some competitors.

Major Acquisitions

Symetra Health

  • Year: 2021
  • Acquisition Price (USD millions): 350
  • Strategic Rationale: Expanded market reach in the Phoenix, Arizona market and added complementary service offerings.

Growth Trajectory and Initiatives

Historical Growth: Growth has been driven by both organic expansion and acquisitions of surgical facilities.

Future Projections: Analysts project continued revenue growth driven by increased demand for outpatient surgical procedures and further acquisitions.

Recent Initiatives: Recent initiatives include expanding the network through strategic acquisitions, focusing on high-growth surgical specialties, and improving operational efficiency.

Summary

Surgery Partners is a leading operator of surgical facilities with a strong network and focus on high-growth specialties. Its growth has been fueled by acquisitions, leading to high debt levels. The company faces competition and regulatory risks but is well-positioned to benefit from the increasing demand for outpatient surgery. Surgery Partners needs to manage its debt and integrate acquisitions effectively to achieve sustainable profitability.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company filings (SEC)
  • Industry reports
  • Analyst estimates

Disclaimers:

This analysis is based on available information and is not financial advice. Market conditions and company performance are subject to change.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Surgery Partners Inc

Exchange NASDAQ
Headquaters Brentwood, TN, United States
IPO Launch date 2015-10-01
CEO & Director Mr. J. Eric Evans
Sector Healthcare
Industry Medical Care Facilities
Full time employees 15000
Full time employees 15000

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; and ancillary services, such as multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.